ANRO vs VSTM: stock comparison and AI forecast
Alto Neuroscience, Inc. (ANRO) and Verastem, Inc. (VSTM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ANRO Alto Neuroscience, Inc.
- Price
- $25.16 +4.5% · 6M
- Market Cap
- $987M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VSTM Verastem, Inc.
- Price
- $9.38 +65.7% · 6M
- Market Cap
- $1.14B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- VSTM is 1.2 times larger than ANRO by market capitalization ($1.14B against $987M).
- Over the last six months VSTM returned +65.7% and ANRO +4.5%.
- VSTM carries 21.73 times debt per unit of equity, against 0.16 times for ANRO.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ANRO | VSTM |
|---|---|---|
| Market Cap | $987M | $1.14B |
| P/B Ratio | 4.50x | 112.86x |
| EPS | $-2.19 | $-1.79 |
| Book Value/Share | $5.59 | $0.08 |
| Revenue/Share | – | $0.83 |
| FCF/Share | $-1.75 | – |
Profitability & Margins
| Metric | ANRO | VSTM |
|---|---|---|
| ROE | -38.4% | -1771.1% |
| ROA | -33.2% | -77.9% |
| ROIC | -37.2% | -153.8% |
| Operating Margin | – | -193.7% |
| Net Margin | – | -178.4% |
| EBT Margin | – | -225.3% |
| Tax Rate | 0.0% | -0.4% |
Financial Health
| Metric | ANRO | VSTM |
|---|---|---|
| Current Ratio | 14.85x | 1.93x |
| Quick Ratio | – | 1.91x |
| D/E Ratio | 0.16x | 21.73x |
| Financial Leverage | 1.16x | 22.73x |
| Interest Coverage | -87.2x | -354.8x |
| Working Capital | $231M | $96M |
Cash Flow
| Metric | ANRO | VSTM |
|---|---|---|
| Operating Cash Flow | -$68M | -$160M |
| Free Cash Flow | -$69M | – |
| Capital Spending | -$560K | – |
Operational Efficiency
| Metric | ANRO | VSTM |
|---|---|---|
| Asset Turnover | – | 0.44x |
| Receivables Turnover | – | 10.2x |
| Days Sales Outstanding | – | 36 days |
Income Statement
| Metric | ANRO | VSTM |
|---|---|---|
| Total Revenue | – | $100M |
| Operating Income | -$88M | -$194M |
| Net Income | -$84M | -$179M |
| R&D Expense | $65M | $180M |
| SG&A Expense | – | $101M |
Dividend & Shareholder Information
| Metric | ANRO | VSTM |
|---|---|---|
| Shares Outstanding | 39M | 122M |
ANRO vs VSTM: stock comparison and AI forecast
Which is bigger, ANRO or VSTM?
VSTM is 1.2 times larger than ANRO by market capitalization ($1.14B against $987M).
Which stock performed better over the last six months, ANRO or VSTM?
Over the last six months VSTM returned +65.7% and ANRO +4.5%.
Which one does Intratio's AI model rank higher, ANRO or VSTM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.